MEDICINA PREVENTIVA Y SALUD PUBLICA
(Ref. CTS-137)
18
July
2025
July 2025
| L | M | X | J | V | S | D |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | |
| 7 | 8 | 9 | 10 | 11 | 12 | 13 |
| 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| 21 | 22 | 23 | 24 | 25 | 26 | 27 |
| 28 | 29 | 30 | 31 |
Scientific production
BACK TO LISTArticle details
| Publication | |
|---|---|
| Title: | TOCILIZUMAB IN COVID-19: FACTORS ASSOCIATED WITH MORTALITY BEFORE AND AFTER TREATMENT |
| Journal title: | FRONTIERS IN PHARMACOLOGY |
| Contribution type: | ARTICULO |
| Volume number: | 12 |
| Number of pages of the publication: | 620187 - |
| Publication year: | 2021 |
| Authors: |
LUIS SARABIA-DE ARDANAZ JOSE M ANDREU-UBERO MIRIAM NAVIDAD-FUENTES MIGUEL ANGEL FERRER-GONZALEZ VICTOR RUIZ-DEL VALLE INMACULADA SALCEDO BELLIDO ROCÍO BARRIOS RODRÍGUEZ MARIA DEL PILAR REQUENA MENDEZ |
[Download BibTex]